Atoosa Rabiee

Had a great last day at #TLM2025 with inspiration and food for 🤔

👀 all 7 women @aasldnews.bsky.social presidents in one room (‼️) for the Women’s Luncheon

🔥🔥🔥discussion by @LaurenFeldMD and division chiefs on recruitment & retention of women hepatologists

#liversky

Next gen hepatology

Session by communication and technology committee

All brilliant speakers!

Proud to have served as the chair of this committee
@aasldnews.bsky.social
#TLM25
#liversky
@howardtleemd.bsky.social

📣 NEW 💫 class of @aasldnews.bsky.social Women’s Leadership Development program mentees & mentors

It was lovely to celebrate you with an inspiring keynote talk from #AASLD25 President Dr. Grace Su

Looking forward to the year ahead!

#TLM2025 #liversky #gisky

➡️What happens when you increase salary transparency?

➡️What is on a chief’s 🧠when negotiating a new hire?

➡️How to ⚖️ accommodations & consistency?

Find out in our 🔥🔥 #TLM2025 panel

@aasldnews.bsky.social #liversky @ast-whcop.bsky.social @ast-licop.bsky.social

Best practices of management of obesity in liver transplant

FANTASTIC work by @drjessicadavis.bsky.social et al leading a controversy conference and consensus paper 👇🏼👇🏼👇🏼

Her beautiful graph won the cover photo 👌🏼

#liversky
#TLM25
@aasldnews.bsky.social
@ast-licop.bsky.social

Great practical talk by @dougsimonetto.bsky.social
#TLM25
#liversky

Recompensation take home points

⏳off all diuretics and medications for HE
📌happens in 1 out of 3 patients depending etiology
🖋️multiple factors affect it
🔎 improves survival and LR mortality
📍Risk of HCC remains the same: don’t stop screening

@anahitarabiee.bsky.social
#liversky
#TLM25

😀🇦🇹 multisociety (gastroenterology & hepatology, diabetology & obesity) consensus on MASLD (& MetALD!)
🤝Well-aligned with @easlnews.bsky.social CPGs
😟Reimbursement currently restricted to semaglutide for T2DM
🤔Reimbursement in your country?

🖇️: rdcu.be/eLAde

#LiverSky @georg-semmler.bsky.social

VA hepatitis C team winning the distinguished advocacy award.
Truly well deserved 👏🏼
#liversky
#TLM25

Kicking off the meeting with some of my favorite people
#TLM25 #liversky

BCLC strategy for prognosis prediction and treatment recommendations: The 2025 update

If you take care of patients with #HCC, do not miss this new update from BCLC

#liversky

@easlnews.bsky.social

www.journal-of-hepatology.eu/article/S016....

In anticipation of registration for @bavenocoop.bsky.social VIII

Do not miss this new publication on
refining Baveno VII criteria for CSPH
individual-patient data meta-analysis

#liversky
pubmed.ncbi.nlm.nih.gov/41138818/
@easlnews.bsky.social

Once bleeding is controlled with banding:

Can duration of octreotide infusion be shortened?

In this RCT, 1 v 5 days of Oct infusion post successful EVL was non inferior in prevention of bleeding and all-cause mortality
#liversky
@amcollegegastro.bsky.social

pubmed.ncbi.nlm.nih.gov/41090987/

📌A dual burden

HCC risk is increased in MetALD compared to MASLD

In a large cohort of VA patients, HCC risk
MASLD>>MetALD>>ALD

#liversky
@easlnews.bsky.social

www.sciencedirect.com/science/arti...

Meta‐Analysis: Immune‐Related Adverse Events Are Associated With Improved Effectiveness of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma irAEs, particularly dermatologic, endocrine and low-grade events, were associated with improved ICIs effectiveness in HCC. Early irAEs detection and corticosteroid management preserve survival benefi...

Anecdotally, I have noticed this in my patients. Great to see a publication supporting this.

Meta-Analysis of irAE using ICI in HCC

irAEs correlated with superior PFS & OS
specially derm, endocrine & low-grade events

#liversky
onlinelibrary.wiley.com/doi/10.1111/...

📌 AGA clinical practice update on ascites and hyponatremia

@amergastroassn.bsky.social

#liversky

www.gastrojournal.org/article/S001...

⏳ Just 5 months left for #BavenoVIII!
🗓️ 27-28 March 2026 (👶 Pediatric Symposium: 29 March)
📍 Baveno, Italy
🌐 The event will take place in a hybrid formula — both in person and online.
🧠 Call for abstracts is now open!
🔗 More info at: baveno8.org
🧵

➡️What #livertransplant candidates should get #GLP1-RA?

➡️Best timing for #bariatricsurgery in transplant?

➡️Data for #GLP1-RA in #cirrhosis?

🚨check out our @amjtransplant.bsky.social best practices for #obesity & liver transplant 👇
doi.org/10.1016/j.aj...

#liversky #GIsky #transplant

Thank you! Always appreciate your input 😊

agreed, I am impressed by amount of fat! LS is less surprising.
Also, nice to "see" you on bluesky :)

Changes in trend and comparison of outcomes of TACE vs TARE as bridge therapy for patients with HCC on LT list

#liversky

@aasldnews.bsky.social

Important study on use of ICI post-transplant

Only one rejection!

#liversky
@aasldnews.bsky.social

journals.lww.com/lt/abstract/...

Ever wonder what happens to your liver after binge drinking?
This study showed
📌increased hepatic fat fraction by 2.5-fold in healthy adults
📌increased liver stiffness
📌increased plasma triglycerides
Good news:
All normalized with 10 days of abstinence
#liversky
www.jhep-reports.eu/cms/10.1016/...

Optimal sequencing post immunotherapy for HCC as first line

A good overview

#liversky
@easlnews.bsky.social
www.jhep-reports.eu/article/S258...

Meta‐Analysis: Utilisation of Hepatocellular Carcinoma Surveillance Meta-analysis of 48 studies (1.28 M individuals) shows HCC surveillance remains underutilised despite guideline recommendations: only 54% of at-risk patients receive any ultrasound-based surveillance...

Eye opening statistics re: HCC surveillance and how underutilized the guidelines are

any HCC surveillance a little over 50%
biannual surveillance 10%

#liversky

onlinelibrary.wiley.com/doi/epdf/10....

RCT comparing TJ liver biopsy and HVPG vs EUS LB and PPG measurement

Would LOVE to hear @juanc60.bsky.social and @virginiahdezgea.bsky.social editorial on this paper

#liversky
@amergastroassn.bsky.social
www.cghjournal.org/article/S154...

Comprehensive review on evolution of immunotherapy for HCC

#liversky
#HCC
@aasldnews.bsky.social
journals.lww.com/hep/abstract...

A great review on a not so common liver disease

"Sarcoid in liver"

#liversky
@aasldnews.bsky.social
journals.lww.com/hep/abstract...

HES V2.0 biomarker panel (AFP, AFP-L3, and DCP, their gradient, if available), ALT, platelets, etiology showed higher sensitivity than GALAD at 12 months for HCC diagnosis

#liversky
@jhepatology.bsky.social
www.journal-of-hepatology.eu/article/S016...

If you are in the field of liver transplant, do not miss the 1st successful porcine liver xenotransplantation to a living recipient

Postoperative xTMA -> significant challenge to long-term success
#Liversky
@jhepatology.bsky.social
www.journal-of-hepatology.eu/article/S016...